aTYR PHARMA INC Operating Income
aTYR PHARMA INC (ATYR) reported Operating Income of -$10.88 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- aTYR PHARMA INC operating income (loss) for the quarter ending 2026-06-30 was -$10.88M.
- aTYR PHARMA INC operating income (loss) for the quarter ending 2026-03-31 was -$11.44M.
- aTYR PHARMA INC operating income (loss) for the quarter ending 2025-12-31 was -$14.80M.
- aTYR PHARMA INC operating income (loss) for the quarter ending 2025-09-30 was -$26.75M.
- aTYR PHARMA INC operating income (loss) for fiscal 2025 was -$77.63M.
- aTYR PHARMA INC operating income (loss) for fiscal 2024 was -$67.91M.
- aTYR PHARMA INC operating income (loss) for fiscal 2023 was -$54.92M.
- aTYR PHARMA INC operating income (loss) for fiscal 2022 was -$46.40M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.88M 10-Q · filed 2026-08-07 | -$22.32M 10-Q · filed 2026-08-07 | -$37.11M derived: sum of 3 quarters · filed 2026-08-07 | -$63.86M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$11.44M 10-Q · filed 2026-05-15 | -$26.23M derived: sum of 2 quarters · filed 2026-05-15 | -$52.98M derived: sum of 3 quarters · filed 2026-05-15 | -$73.29M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$14.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$41.54M derived: sum of 2 quarters · filed 2026-03-05 | -$61.85M derived: sum of 3 quarters · filed 2026-08-07 | -$77.63M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$26.75M 10-Q · filed 2025-11-06 | -$47.06M derived: sum of 2 quarters · filed 2026-08-07 | -$62.83M 10-Q · filed 2025-11-06 | -$78.65M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$20.31M 10-Q · filed 2026-08-07 | -$36.09M 10-Q · filed 2026-08-07 | -$51.91M derived: sum of 3 quarters · filed 2026-08-07 | -$70.05M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$15.77M 10-Q · filed 2026-05-15 | -$31.59M derived: sum of 2 quarters · filed 2026-05-15 | -$49.74M derived: sum of 3 quarters · filed 2026-05-15 | -$67.05M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$15.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$33.96M derived: sum of 2 quarters · filed 2026-03-05 | -$51.28M derived: sum of 3 quarters · filed 2026-03-05 | -$67.91M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$18.14M 10-Q · filed 2025-11-06 | -$35.46M derived: sum of 2 quarters · filed 2025-11-06 | -$52.09M 10-Q · filed 2025-11-06 | -$68.05M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | -$17.32M 10-Q · filed 2025-08-07 | -$33.95M 10-Q · filed 2025-08-07 | -$49.91M derived: sum of 3 quarters · filed 2026-03-05 | -$62.52M derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | -$16.64M 10-Q · filed 2025-05-07 | -$32.59M derived: sum of 2 quarters · filed 2026-03-05 | -$45.21M derived: sum of 3 quarters · filed 2026-03-05 | -$58.77M derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | -$15.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$28.57M derived: sum of 2 quarters · filed 2026-03-05 | -$42.13M derived: sum of 3 quarters · filed 2026-03-05 | -$54.92M 10-K · filed 2026-03-05 |
| 2023-09-30 | -$12.62M 10-Q · filed 2024-11-07 | -$26.17M derived: sum of 2 quarters · filed 2024-11-07 | -$38.96M 10-Q · filed 2024-11-07 | -$46.91M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -$13.56M 10-Q · filed 2024-08-13 | -$26.34M 10-Q · filed 2024-08-13 | -$34.30M derived: sum of 3 quarters · filed 2025-03-13 | -$47.79M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | -$12.79M 10-Q · filed 2024-05-02 | -$20.74M derived: sum of 2 quarters · filed 2025-03-13 | -$34.23M derived: sum of 3 quarters · filed 2025-03-13 | -$46.81M derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | -$7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$21.44M derived: sum of 2 quarters · filed 2025-03-13 | -$34.03M derived: sum of 3 quarters · filed 2025-03-13 | -$46.40M 10-K · filed 2025-03-13 |
| 2022-09-30 | -$13.49M 10-Q · filed 2023-11-09 | -$26.08M derived: sum of 2 quarters · filed 2023-11-09 | -$38.45M 10-Q · filed 2023-11-09 | -$47.09M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$12.58M 10-Q · filed 2023-08-09 | -$24.96M 10-Q · filed 2023-08-09 | -$33.60M derived: sum of 3 quarters · filed 2024-03-14 | -$41.33M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$12.38M 10-Q · filed 2023-05-09 | -$21.02M derived: sum of 2 quarters · filed 2024-03-14 | -$28.75M derived: sum of 3 quarters · filed 2024-03-14 | -$39.19M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$16.37M derived: sum of 2 quarters · filed 2024-03-14 | -$26.81M derived: sum of 3 quarters · filed 2024-03-14 | -$34.02M 10-K · filed 2024-03-14 |
| 2021-09-30 | -$7.73M 10-Q · filed 2022-11-14 | -$18.17M derived: sum of 2 quarters · filed 2022-11-14 | -$25.38M 10-Q · filed 2022-11-14 | -$30.32M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-06-30 | -$10.45M 10-Q · filed 2022-08-15 | -$17.65M 10-Q · filed 2022-08-15 | -$22.59M derived: sum of 3 quarters · filed 2023-03-14 | -$29.10M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-03-31 | -$7.20M 10-Q · filed 2022-05-10 | -$12.14M derived: sum of 2 quarters · filed 2023-03-14 | -$18.65M derived: sum of 3 quarters · filed 2023-03-14 | -$24.97M derived: sum of 4 quarters · filed 2023-03-14 |
| 2020-12-31 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$11.45M derived: sum of 2 quarters · filed 2023-03-14 | -$17.77M derived: sum of 3 quarters · filed 2023-03-14 | -$15.91M 10-K · filed 2023-03-14 |
| 2020-09-30 | -$6.51M 10-Q · filed 2021-11-12 | -$12.83M derived: sum of 2 quarters · filed 2021-11-12 | -$10.97M 10-Q · filed 2021-11-12 | -$16.93M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$6.32M 10-Q · filed 2021-08-11 | -$4.46M 10-Q · filed 2021-08-11 | -$10.42M derived: sum of 3 quarters · filed 2022-03-15 | -$15.92M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $1.86M 10-Q · filed 2021-05-14 | -$4.10M derived: sum of 2 quarters · filed 2022-03-15 | -$9.60M derived: sum of 3 quarters · filed 2022-03-15 | -$15.24M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$11.46M derived: sum of 2 quarters · filed 2022-03-15 | -$17.10M derived: sum of 3 quarters · filed 2022-03-15 | -$22.98M 10-K · filed 2022-03-15 |
| 2019-09-30 | -$5.50M 10-Q · filed 2020-11-13 | -$11.14M derived: sum of 2 quarters · filed 2020-11-13 | -$17.02M 10-Q · filed 2020-11-13 | -$22.98M derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | -$5.64M 10-Q · filed 2020-08-13 | -$11.52M 10-Q · filed 2020-08-13 | -$17.48M derived: sum of 3 quarters · filed 2021-03-24 | -$24.16M derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | -$5.88M 10-Q · filed 2020-05-12 | -$11.84M derived: sum of 2 quarters · filed 2021-03-24 | -$18.52M derived: sum of 3 quarters · filed 2021-03-24 | -$28.48M derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | -$5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$12.64M derived: sum of 2 quarters · filed 2021-03-24 | -$22.60M derived: sum of 3 quarters · filed 2021-03-24 | -$32.82M 10-K · filed 2021-03-24 |
| 2018-09-30 | -$6.68M 10-Q · filed 2019-11-14 | -$16.64M derived: sum of 2 quarters · filed 2019-11-14 | -$26.86M 10-Q · filed 2019-11-14 | -$38.06M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | -$9.96M 10-Q · filed 2019-08-14 | -$20.18M 10-Q · filed 2019-08-14 | -$31.38M derived: sum of 3 quarters · filed 2020-03-26 | -$42.21M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | -$10.22M 10-Q · filed 2019-05-14 | -$21.42M derived: sum of 2 quarters · filed 2020-03-26 | -$32.25M derived: sum of 3 quarters · filed 2020-03-26 | -$44.15M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | -$11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$22.03M derived: sum of 2 quarters · filed 2020-03-26 | -$33.93M derived: sum of 3 quarters · filed 2020-03-26 | -$47.15M 10-K · filed 2020-03-26 |
| 2017-09-30 | -$10.83M 10-Q · filed 2018-11-14 | -$22.73M derived: sum of 2 quarters · filed 2018-11-14 | -$35.95M 10-Q · filed 2018-11-14 | -$48.47M derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-06-30 | -$11.91M 10-Q · filed 2018-08-14 | -$25.12M 10-Q · filed 2018-08-14 | -$37.65M derived: sum of 3 quarters · filed 2019-03-26 | -$51.51M derived: sum of 4 quarters · filed 2019-03-26 |
| 2017-03-31 | -$13.21M 10-Q · filed 2018-05-15 | -$25.74M derived: sum of 2 quarters · filed 2019-03-26 | -$39.60M derived: sum of 3 quarters · filed 2019-03-26 | -$55.04M derived: sum of 4 quarters · filed 2019-03-26 |
| 2016-12-31 | -$12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$26.39M derived: sum of 2 quarters · filed 2019-03-26 | -$41.83M derived: sum of 3 quarters · filed 2019-03-26 | -$57.94M 10-K · filed 2019-03-26 |
| 2016-09-30 | -$13.87M 10-Q · filed 2017-11-14 | -$29.30M derived: sum of 2 quarters · filed 2017-11-14 | -$45.41M 10-Q · filed 2017-11-14 | -$61.90M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | -$15.43M 10-Q · filed 2017-08-14 | -$31.55M 10-Q · filed 2017-08-14 | -$48.03M derived: sum of 3 quarters · filed 2018-03-20 | -$59.34M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | -$16.11M 10-Q · filed 2017-05-11 | -$32.60M derived: sum of 2 quarters · filed 2018-03-20 | -$43.91M derived: sum of 3 quarters · filed 2018-03-20 | -$54.81M derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | -$16.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$27.80M derived: sum of 2 quarters · filed 2018-03-20 | -$38.69M derived: sum of 3 quarters · filed 2018-03-20 | -$47.62M 10-K · filed 2018-03-20 |
| 2015-09-30 | -$11.31M 10-Q · filed 2016-11-14 | -$22.21M derived: sum of 2 quarters · filed 2016-11-14 | -$31.13M 10-Q · filed 2016-11-14 | -$37.16M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$10.90M 10-Q · filed 2016-08-10 | -$19.82M 10-Q · filed 2016-08-10 | -$25.85M derived: sum of 3 quarters · filed 2017-03-16 | -$32.08M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$8.92M 10-Q · filed 2016-05-11 | -$14.95M derived: sum of 2 quarters · filed 2017-03-16 | -$21.18M derived: sum of 3 quarters · filed 2017-03-16 | -$26.55M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$12.26M derived: sum of 2 quarters · filed 2017-03-16 | -$17.62M derived: sum of 3 quarters · filed 2017-03-16 | -$23.55M 10-K · filed 2017-03-16 |
| 2014-09-30 | -$6.23M 10-Q · filed 2015-11-10 | -$11.59M derived: sum of 2 quarters · filed 2015-11-10 | -$17.52M 10-Q · filed 2015-11-10 | |
| 2014-06-30 | -$5.36M 10-Q · filed 2015-08-12 | -$11.29M 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | -$5.93M 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | -$19.54M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |